Common diabetes drug shows promise as treatment for COVID-19 lung inflammation
Metformin is a widely prescribed blood sugar-lowering drug. It is often used as an early therapy (in combination with diet and lifestyle changes) for type 2 diabetes, which afflicts more than 34 million Americans.
Metformin works by lowering glucose production in the liver, reducing blood sugar levels that, in turn, improve the body's response to insulin.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
More News: COVID-19 | Diabetes | Diabetes Type 2 | Diets | Endocrinology | Fortamet | Insulin | Liver | Metformin | Nutrition | Pharmaceuticals | Sugar | Urology & Nephrology